Travere Therapeutics Inc (TVTX)

10:42 AM

Will Travere’s Removal From Key Russell Value Indices Change Travere Therapeutics' (TVTX) Narrative? - simplywall.st

10:42 AM

07:09 AM

Everest Medicines Announces Close of Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib - The Manila Times

07:09 AM

Jul 06, 2026

Travere Therapeutics Wins Much-Awaited Approval For Drug In Rare Kidney Disease - Stocktwits

Jul 06, 2026

Jul 03, 2026

Travere Therapeutics: Filspari Is Becoming A Rare Kidney Disease Platform (NASDAQ:TVTX) - Seeking Alpha

Jul 03, 2026

Jul 02, 2026

TVTX, LGND Stocks In Spotlight Ahead Of Monday’s FDA Call On Kidney Drug Filspari - Stocktwits

Jul 02, 2026

Jun 30, 2026

Travere Therapeutics Receives Notice of Allowance from the U.S. P - The National Law Review

Jun 30, 2026

Jun 29, 2026

Travere Therapeutics, Inc.(NasdaqGM: TVTX) dropped from Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Understanding Momentum Shifts in (TVTX) - Stock Traders Daily

Jun 29, 2026

Jun 28, 2026

Travere Therapeutics, Inc.(NasdaqGM:TVTX) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 28, 2026

TVTX Stock On Track To Hit Near 20-Year Highs After Filspari Becomes The Only Approved FSGS Treatment - Stocktwits

Jun 28, 2026

Jun 28, 2026

Enterprise value to revenue forward of Travere Therapeutics, Inc. – NASDAQ:TVTX - TradingView

Jun 28, 2026

Jun 28, 2026

Price to earnings forward of Travere Therapeutics, Inc. – NASDAQ:TVTX - TradingView

Jun 28, 2026

Jun 28, 2026

Travere Therapeutics, Inc.(NasdaqGM: TVTX) dropped from Russell 3000 Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 27, 2026

Enterprise value to EBITDA forward of Travere Therapeutics, Inc. – NASDAQ:TVTX - TradingView

Jun 27, 2026

Jun 27, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review

Jun 27, 2026

Jun 27, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Travere Thera - The National Law Review

Jun 27, 2026

Jun 27, 2026

Price to sales forward of Travere Therapeutics, Inc. – NASDAQ:TVTX - TradingView

Jun 27, 2026

Jun 26, 2026

Travere Therapeutics, Inc. Actuals & Estimates (NASDAQ:TVTX) - TradingView

Jun 26, 2026

Jun 25, 2026

TVTX Maintained by Guggenheim -- Price Target Raised to $65 - GuruFocus

Jun 25, 2026

Jun 25, 2026

TVTX Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 24, 2026

Travere Therapeutics stock hits 52-week high at 56.9 USD By Investing.com - Investing.com Australia

Jun 24, 2026

Jun 24, 2026

Travere Therapeutics stock hits 52-week high at 56.9 USD - Investing.com

Jun 24, 2026

Jun 24, 2026

Travere Therapeutics Inc (TVTX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 24, 2026

Jun 23, 2026

Travere Therapeutics Inc (TVTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 23, 2026

Jun 22, 2026

Form 4 Travere Therapeutics Inc For: 22 June By Investing.com - Investing.com South Africa

Jun 22, 2026

Jun 22, 2026

Travere Therapeutics (NASDAQ: TVTX) CMO gifts 468 shares in Form 4 - Stock Titan

Jun 22, 2026

Jun 22, 2026

TVTX Maintains by Wedbush -- Price Target Raised to $61.00 - GuruFocus

Jun 22, 2026

Jun 22, 2026

Travere Therapeutics Shows Favorable Setup With Filspari as Growth Asset, Wedbush Says - marketscreener.com

Jun 22, 2026

Jun 22, 2026

Travere and Everest Medicines Strike $1.1 Billion Rare Kidney Disease Deal - The Healthcare Technology Report.

Jun 22, 2026

Jun 22, 2026

A Quick Look at Today's Ratings for Travere Therapeutic(TVTX.US), With a Forecast Between $49 to $67 - Moomoo

Jun 22, 2026

Jun 21, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Jun 21, 2026

Jun 18, 2026

TVTX Maintained by Evercore ISI Group -- Price Target Raised to $60 - GuruFocus

Jun 18, 2026

Jun 18, 2026

Travere Therapeutics Inc (TVTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 18, 2026

Jun 18, 2026

Travere Therapeutics Inc (TVTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 18, 2026

Jun 18, 2026

Travere Therapeutics Inc (TVTX) Institutional Confidence - TradingKey

Jun 18, 2026

Jun 18, 2026

Travere Therapeutics stock hits 52-week high at 54.49 USD By Investing.com - Investing.com Nigeria

Jun 18, 2026

Jun 18, 2026

Travere Therapeutics Inc (TVTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026

Jun 18, 2026

Travere Therapeutics Inc (TVTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 18, 2026

Jun 18, 2026

Avoiding Lag: Real-Time Signals in (TVTX) Movement - Stock Traders Daily

Jun 18, 2026

Jun 17, 2026

Travere Therapeutics Inc (TVTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 17, 2026

Travere Therapeutics Announces R&D Leadership Transition Plan - The Globe and Mail

Jun 17, 2026

Jun 17, 2026

Travere Therapeutics stock hits 52-week high at 54.49 USD - Investing.com

Jun 17, 2026

Jun 17, 2026

Travere Therapeutics announces leadership changes in R&D By Investing.com - Investing.com South Africa

Jun 17, 2026

Jun 17, 2026

Travere Therapeutics, Inc. (TVTX) latest stock news and headlines - Yahoo Finance Singapore

Jun 17, 2026

Jun 17, 2026

Travere Therapeutics (TVTX) Announces Leadership Change in Resea - GuruFocus

Jun 17, 2026